{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T22:29:22Z","timestamp":1791066562037,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[1997,9,1]],"date-time":"1997-09-01T00:00:00Z","timestamp":873072000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Med"],"published-print":{"date-parts":[[1997,9]]},"DOI":"10.1038\/nm0997-984","type":"journal-article","created":{"date-parts":[[2004,8,19]],"date-time":"2004-08-19T02:14:32Z","timestamp":1092881672000},"page":"984-989","source":"Crossref","is-referenced-by-count":162,"title":["Acquired CD40-ligand deficiency in chronic lymphocytic leukemia"],"prefix":"10.1038","volume":"3","author":[{"given":"Mark","family":"Cantwell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tinh","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"Pappas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Kipps","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"BFnm0997984_CR1","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.4049\/jimmunol.151.5.2497","volume":"151","author":"M Roy","year":"1993","unstructured":"Roy, M., Waldschmidt, T., Aruffo, A., Ledbetter, J.A. & Noelle, R.J. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD49+ T cells. J. Immunol. 151, 2497\u20132510 (1993).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR2","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.4049\/jimmunol.151.4.1777","volume":"151","author":"BE Castle","year":"1993","unstructured":"Castle, B.E., Kishimoto, K., Steams, C., Brown, M.L. & Kehry, M.R. Regulation of expression of the ligand for CD40 on T helper lymphocytes. J. Immunol. 151, 1777\u20131788 (1993).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR3","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1146\/annurev.iy.12.040194.004313","volume":"12","author":"J Banchereau","year":"1994","unstructured":"Banchereau, J. et al. The CD40 antigen and its ligand. Annu. Rev. Immunol. 12, 881\u2013922 (1994).","journal-title":"Annu. Rev. Immunol."},{"key":"BFnm0997984_CR4","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/367425a0","volume":"367","author":"EA Clark","year":"1994","unstructured":"Clark, E.A. & Ledbetter, J.A. How B and T cells talk to each other. Nature 367, 425\u2013428 (1994).","journal-title":"Nature"},{"key":"BFnm0997984_CR5","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1084\/jem.178.5.1555","volume":"178","author":"AJ Van den Eertwegh","year":"1993","unstructured":"Van den Eertwegh, A.J. et al. In vivo CD40-gp39 interactions are essential for thymus-dependent humoral immunity. I. In vivo expression of CD40 ligand, cytokines and antibody production delineates sites of cognate T-B Cell interactions. J. Exp. Med. 178, 1555\u20131565 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnm0997984_CR6","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1084\/jem.181.4.1293","volume":"181","author":"M Casamayor-Palleja","year":"1995","unstructured":"Casamayor-Palleja, M., Khan, M. & MacLennan, I.C. A subset of CD4+ memory T cells contains preformed CD40 ligand that is rapidly but transiently expressed on their surface after activation through the T Cell receptor complex. J. Exp. Med. 181, 1293\u20131301 (1995).","journal-title":"J. Exp. Med."},{"key":"BFnm0997984_CR7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.4049\/jimmunol.155.2.556","volume":"155","author":"S Han","year":"1995","unstructured":"Han, S. et al. Cellular interaction in germinal centers: Roles of CD40 ligand and B7-2 in established germinal centers. J. Immunol. 155, 556\u2013567 (1995).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR8","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/0092-8674(93)90668-G","volume":"72","author":"A Aruffo","year":"1993","unstructured":"Aruffo, A. et al. The CD40 ligand, gp39, is defective in activated T cells from patients with X-linked hyper-IgM syndrome. Cell 72, 291\u2013300 (1993).","journal-title":"Cell"},{"key":"BFnm0997984_CR9","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1126\/science.7679801","volume":"259","author":"RC Allen","year":"1993","unstructured":"Allen, R.C. et al. CD40 ligand gene defects responsible for X-linked hyper-IgM syndrome. Science 259, 990\u2013993 (1993).","journal-title":"Science"},{"key":"BFnm0997984_CR10","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/361541a0","volume":"361","author":"JP DiSanto","year":"1993","unstructured":"DiSanto, J.P., Bonnefoy, J.Y., Gauchat, J.F., Fischer, A. & de Saint Basile, G. CD40 ligand mutations in X-iinked immunodeficiency with hyper-IgM. Nature 361, 541\u2013543 (1993).","journal-title":"Nature"},{"key":"BFnm0997984_CR11","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/361539a0","volume":"361","author":"U Korthauer","year":"1993","unstructured":"Korthauer, U. et al. Defective expression of T-Cell CD40 ligand causes X-linked immunodeficiency with hyper-IgM. Nature 361, 539\u2013541 (1993).","journal-title":"Nature"},{"key":"BFnm0997984_CR12","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/378617a0","volume":"378","author":"IS Grewal","year":"1995","unstructured":"Grewal, I.S., Xu, J. & Flavell, R.A. Impairment of antigen-specific T-Cell priming in mice lacking CD40 ligand. Nature 378, 617\u2013620 (1995).","journal-title":"Nature"},{"key":"BFnm0997984_CR13","first-page":"1017","volume-title":"William's Hematology","author":"TJ Kipps","year":"1995","unstructured":"Kipps, T.J. Chronic lymphocytic leukemia and related diseases. in William's Hematology. (eds. Beutler, E., Lichtman, M.A., Coller, B.S. & Kipps, T.J.) 1017\u20131039 (McGraw-Hill, Inc., New York, 1995)."},{"key":"BFnm0997984_CR14","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1136\/jcp.39.7.713","volume":"39","author":"TJ Hamblin","year":"1986","unstructured":"Hamblin, T.J., Oscier, D.G. & Young, B.J. Autoimmunity in chronic lymphocytic leukaemia. J. Clin. Pathol. 39, 713\u2013716 (1986).","journal-title":"J. Clin. Pathol."},{"key":"BFnm0997984_CR15","first-page":"514","volume":"11","author":"CA Westbrook","year":"1984","unstructured":"Westbrook, C.A. & Golde, D.W. Clinical problems in hairy Cell leukemia: Diagnosis and management. Semin. Oncol. 11, 514\u2013522 (1984).","journal-title":"Semin. Oncol."},{"key":"BFnm0997984_CR16","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1056\/NEJM199508173330707","volume":"333","author":"FS Rosen","year":"1995","unstructured":"Rosen, F.S., Cooper, M.D. & Wedgwood, R.J. The primary immunodeficiencies. N. Engl. J. Med. 333, 431\u2013440 (1995).","journal-title":"N. Engl. J. Med."},{"key":"BFnm0997984_CR17","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/BF00915481","volume":"3","author":"G Lucivero","year":"1983","unstructured":"Lucivero, G., Prchal, J.T., Lawton, A.R., Antonaci, S. & Bonomo, L. Abnormal T-Cell functions in B-Cell chronic lymphocytic leukemia do not imply T-lymphocyte involvement in the leukemic process: Report of a case with demonstrated \u201cpolyclonality\u201d of T lymphocytes. J. Clin. Immunol. 3, 111\u2013116 (1983).","journal-title":"J. Clin. Immunol."},{"key":"BFnm0997984_CR18","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1182\/blood.V60.5.1075.1075","volume":"60","author":"T Han","year":"1982","unstructured":"Han, T. et al. Lack of autologous mixed lymphocyte reaction in patients with chronic lymphocytic leukemia: Evidence for autoreactive T-Cell dysfunction not correlated with phenotype, karyotype, or clinical status. Blood 60, 1075\u20131081 (1982).","journal-title":"Blood"},{"key":"BFnm0997984_CR19","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1182\/blood.V67.3.578.578","volume":"67","author":"NE Kay","year":"1986","unstructured":"Kay, N.E. & Kaplan, M.E. Defective T Cell responsiveness in chronic lymphocytic leukemia: Analysis of activation events. Blood 67, 578\u2013581 (1986).","journal-title":"Blood"},{"key":"BFnm0997984_CR20","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1365-2141.1984.tb02870.x","volume":"57","author":"NE Kay","year":"1984","unstructured":"Kay, N.E. & Kaplan, M.E. Defective expression of T Cell antigens in chronic lymphocytic leukaemia: Relationship to T Cell dysfunction. Br. J. Haematol. 57, 105\u2013111 (1984).","journal-title":"Br. J. Haematol."},{"key":"BFnm0997984_CR21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1182\/blood.V67.2.279.279","volume":"67","author":"O Ayanlar-Batuman","year":"1986","unstructured":"Ayanlar-Batuman, O., Ebert, E. & Hauptman, S.P. Defective interleukin-2 production and responsiveness by T cells in patients with chronic lymphocytic leukemia of B Cell variety. Blood 67, 279\u2013284 (1986).","journal-title":"Blood"},{"key":"BFnm0997984_CR22","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1002\/1097-0142(197703)39:3<1168::AID-CNCR2820390323>3.0.CO;2-G","volume":"39","author":"LA Fernandez","year":"1977","unstructured":"Fernandez, L.A., MacSween, J.M. & Langley, G.R. T Cell function in untreated B Cell chronic lymphocytic leukemia. Cancer 39, 1168\u20131174 (1977).","journal-title":"Cancer"},{"key":"BFnm0997984_CR23","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.4049\/jimmunol.125.3.1216","volume":"125","author":"CD Platsoucas","year":"1980","unstructured":"Platsoucas, C.D. et al. Defective spontaneous and antibody-dependent cytotoxicity mediated by E-rosette-positive and E-rosette-negative cells in untreated patients with chronic lymphocytic leukemia: Augmentation by in vitro treatment with interferon. J. Immunol. 125, 1216\u20131223 (1980).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR24","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/0090-1229(80)90116-6","volume":"17","author":"RT Callery","year":"1980","unstructured":"Callery, R.T. et al. Functional abnormalities associated with T lymphocytes from patients with chronic lymphocytic leukemia. Clin. Immunol. Immunopathol. 17, 451\u2013458 (1980).","journal-title":"Clin. Immunol. Immunopathol."},{"key":"BFnm0997984_CR25","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1002\/1097-0142(19811115)48:10<2191::AID-CNCR2820481013>3.0.CO;2-9","volume":"48","author":"G Semenzato","year":"1981","unstructured":"Semenzato, G., Pezzutto, A., Agostini, C., Albertin, M. & Gasparotto, G. T-lymphocyte subpopulations in chronic lymphocytic leukemia: A quantitative and functional study. Cancer 48, 2191\u20132197 (1981).","journal-title":"Cancer"},{"key":"BFnm0997984_CR26","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1111\/j.1365-2141.1981.tb07274.x","volume":"49","author":"E Matutes","year":"1981","unstructured":"Matutes, E., Wechsler, A., Gomez, R., Cherchi, M. & Catovsky, D. Unusual T-Cell phenotype in advanced B-chronic lymphocytic leukaemia. Br. J. Haematol. 49, 635\u2013642 (1981).","journal-title":"Br. J. Haematol."},{"key":"BFnm0997984_CR27","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1182\/blood.V74.2.786.786","volume":"74","author":"TH Totterman","year":"1989","unstructured":"Totterman, T.H., Carlsson, M., Simonsson, B., Bengtsson, M. & Nilsson, K. T-Cell activation and subset patterns are altered in B-CLL and correlate with the stage of the disease. Blood 74, 786\u2013792 (1989).","journal-title":"Blood"},{"key":"BFnm0997984_CR28","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.4049\/jimmunol.156.5.1781","volume":"156","author":"HR Patel","year":"1996","unstructured":"Patel, H.R., Oshiba, A., Jeppson, J.D. & Gelfand, E.W. Differential expression of CD40 ligand on T Cell subsets: Implications for different roles of CD45RA+ and CD45RO+ cells in IgE production. J. Immunol. 156, 1781\u20131787 (1996).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR29","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1084\/jem.179.3.999","volume":"179","author":"M Lotz","year":"1994","unstructured":"Lotz, M., Ranheim, E. & Kipps, T.J. Transforming growth factor beta as endogenous growth inhibitor of chronic lymphocytic leukemia B cells. J. Exp. Med. 179, 999\u20131004 (1994).","journal-title":"J. Exp. Med."},{"key":"BFnm0997984_CR30","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/eji.1830240402","volume":"24","author":"C van Kooten","year":"1994","unstructured":"van Kooten, C. et al. B cells regulate expression of CD40 ligand on activated T cells by lowering the mRNA level and through the release of soluble CD40. Eur. J. Immunol. 24, 787\u2013792 (1994).","journal-title":"Eur. J. Immunol."},{"key":"BFnm0997984_CR31","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.4049\/jimmunol.154.10.4996","volume":"154","author":"AC Grammer","year":"1995","unstructured":"Grammer, A.C. et al. The CD40 ligand expressed by human B cells costimulates B Cell responses. J. Immunol. 154, 4996\u20135010 (1995).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR32","doi-asserted-by":"crossref","first-page":"598","DOI":"10.4049\/jimmunol.152.2.598","volume":"152","author":"MJ Yellin","year":"1994","unstructured":"Yellin, M.J. et al. CD40 molecules induce down-modulation and endocytosis of T cell surface T cell-B cell activating molecule\/CD40-L. Potential role in regulating helper effector function. J. Immunol. 152, 598\u2013608 (1994).","journal-title":"J. Immunol."},{"key":"BFnm0997984_CR33","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1016\/0092-8674(77)90087-3","volume":"11","author":"B Storrie","year":"1977","unstructured":"Storrie, B. & Edelson, P.J. Distribution of concanavalin A in fibroblasts: Direct endocytosis versus surface capping. Cell 11, 707\u2013717 (1977).","journal-title":"Cell"},{"key":"BFnm0997984_CR34","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1083\/jcb.87.1.132","volume":"87","author":"JL Salisbury","year":"1980","unstructured":"Salisbury, J.L., Condeelis, J.S. & Satir, P. Role of coated vesicles, microfilaments and calmodulin in receptor-mediated endocytosis by cultured B lymphoblastoid cells. J. Cell Biol. 87, 132\u2013141 (1980).","journal-title":"J. Cell Biol."},{"key":"BFnm0997984_CR35","doi-asserted-by":"publisher","first-page":"925","DOI":"10.1084\/jem.177.4.925","volume":"177","author":"EA Ranheim","year":"1993","unstructured":"Ranheim, E.A. & Kipps, T.J. Activated T cells induce expression of B7\/BB1 on normal or leukemic B cells through a CD40-dependent signal. J. Exp. Med. 177, 925\u2013935 (1993).","journal-title":"J. Exp. Med."},{"key":"BFnm0997984_CR36","first-page":"101","volume":"3","author":"LD Notarangelo","year":"1992","unstructured":"Notarangelo, L.D., Duse, M. & Ugazio, A.G. Immunodeficiency with hyper-IgM (HIM). Immunodefic. Rev. 3, 101\u2013121 (1992).","journal-title":"Immunodefic. Rev."},{"key":"BFnm0997984_CR37","first-page":"494","volume":"10","author":"E Rossi","year":"1996","unstructured":"Rossi, E. et al. Zeta chain and CD28 are poorly expressed on T lymphocytes from chronic lymphocytic leukemia. Leukemia 10, 494\u2013497 (1996).","journal-title":"Leukemia"},{"key":"BFnm0997984_CR38","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1126\/science.1465616","volume":"258","author":"H Mizoguchi","year":"1992","unstructured":"Mizoguchi, H. et al. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice. Science 258, 1795\u20131798 (1992).","journal-title":"Science"},{"key":"BFnm0997984_CR39","doi-asserted-by":"publisher","first-page":"2830","DOI":"10.1002\/eji.1830251018","volume":"25","author":"F Bowen","year":"1995","unstructured":"Bowen, F., Haluskey, J. & Quill, H. Altered CD40 ligand induction in tolerant T lymphocytes. Eur. J. Immunol. 25, 2830\u20132834 (1995).","journal-title":"Eur. J. Immunol."},{"key":"BFnm0997984_CR40","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1002\/eji.1830230430","volume":"23","author":"P Hermann","year":"1993","unstructured":"Hermann, P. et al. Expression of a 32-kDa ligand for the CD40 antigen on activated human T lymphocytes. Eur. J. Immunol. 23, 961\u2013964 (1993).","journal-title":"Eur. J. Immunol."},{"key":"BFnm0997984_CR41","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/BF00199769","volume":"20","author":"S Paulie","year":"1985","unstructured":"Paulie, S. et al. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes. Cancer Immunol. Immunother. 20, 23\u201328 (1985).","journal-title":"Cancer Immunol. Immunother."},{"key":"BFnm0997984_CR42","first-page":"443","volume":"8","author":"H Ben-Aissa","year":"1988","unstructured":"Ben-Aissa, H. et al. Human bladder cancer associated antigens: evaluation of antigenicity in TCC tissues of different grades and in normal urothelium. Anticancer. Res. 8, 443\u2013449 (1988).","journal-title":"Anticancer. Res."},{"key":"BFnm0997984_CR43","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/ijc.2910580114","volume":"58","author":"D Hutchins","year":"1994","unstructured":"Hutchins, D. & Steel, C.M. Regulation of ICAM-1 (CD54) expression in human breast cancer cell lines by interleukin 6 and fibroblast-derived factors. Int. J. Cancer 58, 80\u201384 (1994).","journal-title":"Int. J. Cancer"},{"key":"BFnm0997984_CR44","first-page":"1387","volume":"148","author":"J Pammer","year":"1996","unstructured":"Pammer, J. et al. CD40 antigen is expressed by endotheliai cells and tumor cells in Kaposi's sarcoma. Am. J. Pathol. 148, 1387\u20131396 (1996).","journal-title":"Am. J. Pathol."},{"key":"BFnm0997984_CR45","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1084\/jem.183.5.2129","volume":"183","author":"P Borrow","year":"1996","unstructured":"Borrow, P. et al. CD40L-deficient mice show deficits in antiviral immunity and have an impaired memory CD8+ CTL response. J. Exp. Med. 183, 2129\u20132142 (1996).","journal-title":"J. Exp. Med."},{"key":"BFnm0997984_CR46","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1084\/jem.183.2.693","volume":"183","author":"E Stuber","year":"1996","unstructured":"Stuber, E., Strober, W. & Neurath, M. Blocking the CD40L-CD40 interaction in vivo specifically prevents the priming of T helper 1 cells through the inhibition of interleukin 12 secretion. J. Exp. Med. 183, 693\u2013698 (1996).","journal-title":"J. Exp. Med."}],"container-title":["Nature Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nm0997-984","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0997-984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nm0997-984.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T23:36:23Z","timestamp":1684452983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nm0997-984"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,9]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[1997,9]]}},"alternative-id":["BFnm0997984"],"URL":"https:\/\/doi.org\/10.1038\/nm0997-984","relation":{},"ISSN":["1078-8956","1546-170X"],"issn-type":[{"value":"1078-8956","type":"print"},{"value":"1546-170X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,9]]}}}